| 注册
首页|期刊导航|基础医学与临床|羧胺三唑乳清酸盐对人胰腺癌细胞系增殖及脂肪酸合成代谢的影响

羧胺三唑乳清酸盐对人胰腺癌细胞系增殖及脂肪酸合成代谢的影响

郭泓江 徐也婷 张迪雅 仇佳星 王钰铖 鞠瑞 郭磊

基础医学与临床2024,Vol.44Issue(4):440-446,7.
基础医学与临床2024,Vol.44Issue(4):440-446,7.DOI:10.16352/j.issn.1001-6325.2024.04.0440

羧胺三唑乳清酸盐对人胰腺癌细胞系增殖及脂肪酸合成代谢的影响

Effect of carboxyamidotriazole-orotate on proliferation and fatty acid anabolism of human pancreatic cancer cell lines

郭泓江 1徐也婷 1张迪雅 1仇佳星 1王钰铖 1鞠瑞 1郭磊1

作者信息

  • 1. 中国医学科学院基础医学研究所 北京协和医学院基础学院 药理学系,北京 100005
  • 折叠

摘要

Abstract

Objective To study the effect of carboxyamidotriazole-orotate(CTO)on the proliferation and fatty acid anabolism regulation of human pancreatic cancer cells.Methods Human pancreatic cancer cell lines AsPC-1,AsPC-1/GEM(AR),PANC-1 and MiaPaCa-2 were used as the study subjects;cell survival rate was detected by sulfo-nylrhodamine B(SRB);the mRNA level of key genes for fatty acid synthesis was detected by qPCR;the protein level of the AMPK/ACC pathway was detected by Western blot;intracellular lipid metabolites were examined by liquid chromatography-mass spectrometry(LC-MS).Results Comparing to control group,CTO significantly de-creased the cell viability of AsPC-1,AR,PANC-1,and MiaPaCa-2(P<0.05).CTO down-regulated the mRNA level of key fatty acid synthesis genes(P<0.05).CTO significantly reduced the protein expression of AMPK,ACC and c-Myc(P<0.05),while increasing the protein expression of p-AMPK and p-ACC(P<0.05).CTO decreased lipid metabolite content in AR cells(P<0.05).Conclusions CTO attenuates cellular fatty acid anabolism by inhibition of oncogene c-Myc expression and AMPK/ACC pathway,down-regulates the expression of fatty acid synthesis-related genes,and then inhibits proliferation of the human pancreatic cancer cell lines AsPC-1,AR,PANC-1 and MiaPaCa-2.

关键词

羧胺三唑乳清酸盐/胰腺癌/增殖/脂肪酸合成代谢

Key words

carboxyamidotriazole-orotate/pancreatic cancer/proliferation/fatty acid anabolism

分类

医药卫生

引用本文复制引用

郭泓江,徐也婷,张迪雅,仇佳星,王钰铖,鞠瑞,郭磊..羧胺三唑乳清酸盐对人胰腺癌细胞系增殖及脂肪酸合成代谢的影响[J].基础医学与临床,2024,44(4):440-446,7.

基金项目

国家自然科学基金(82002094) (82002094)

中国医学科学院医学与健康科技创新工程(2022-I2M-2-002) (2022-I2M-2-002)

北京市自然科学基金(7222254) (7222254)

基础医学与临床

OACSTPCD

1001-6325

访问量0
|
下载量0
段落导航相关论文